Jon G. Mabley
Jon G. Mabley publishes mostly in Oncology, Cardiology and Cardiovascular Medicine and Physiology, on topics such as PARP inhibition in cancer therapy, Pancreatic function and diabetes and Adenosine and Purinergic Signaling.
- World rank
- #340,963 of 7,710,434 ranked researchers
- Rank in United States
- #122,614 of 1,627,098
- Works
- 98
- Citations
- 8.1k
- Citations per work
- 82.7
What does Jon G. Mabley research?
Jon G. Mabley's work is mostly in Medicine (28%), Biochemistry, Genetics and Molecular Biology (13%), Immunology and Microbiology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else5051.5%
- Health Sciences2828.5%
- Medicine2828.5%
- Life Sciences2020.0%
- 1Oncology13% of their works
- 2Cardiology and Cardiovascular Medicine9% of their works
- 3Physiology8% of their works
- 4Immunology7% of their works
- 5Surgery6% of their works
- 6Molecular Biology6% of their works
Research topics
Which keywords describe Jon G. Mabley's research?
The keywords of their largest research topics: BRCA Mutation, PARP Inhibitors, Oxidative Stress, Inflammation, Pancreatic Islets, ß-Cell Dysfunction, Adenosine Receptors and Purinergic Signalling.
- Two-pore Channels
- Lysosomal Calcium Signaling
- Type 1 Diabetes
- Nitric Oxide
- Long-QT Syndrome
- Purinergic Signalling
- ß-Cell Dysfunction
- Inflammation
- PARP Inhibitors
- BRCA Mutation
- Oxidative Stress
- Pancreatic Islets
- Adenosine Receptors
- Arrhythmias
- Endothelial Dysfunction
- Genetics
- Fructose
- Metabolic Syndrome
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- BRCA Mutation311 topic
- PARP Inhibitors311 topic
- Oxidative Stress242 topics
- Inflammation232 topics
- Pancreatic Islets151 topic
- ß-Cell Dysfunction151 topic
- Adenosine Receptors141 topic
- Purinergic Signalling141 topic
- Arrhythmias101 topic
- Long-QT Syndrome101 topic
- Endothelial Dysfunction91 topic
- Nitric Oxide91 topic
- Genetics81 topic
- Type 1 Diabetes81 topic
- Fructose71 topic
- Lysosomal Calcium Signaling71 topic
- Metabolic Syndrome71 topic
- Two-pore Channels71 topic
Where does Jon G. Mabley work?
Jon G. Mabley's main affiliation in the publication record is Inotek Pharmaceuticals (United States), United States.
How many publications and citations does Jon G. Mabley have?
OpenAlex counts 98 works and 8,103 citations for Jon G. Mabley, an h-index of 54, ranking #340,963 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Jon G. Mabley. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.